JOSHUA GORDON RAMSAY DO, MBA
Prescription History 1093245607
Internal Medicine - Hematology & Oncology in Ogden, UT
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for JOSHUA GORDON RAMSAY DO, MBA, an active Hematology & Oncology specialist practicing in Ogden, UT. Our medical registry currently tracks 10 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 261 documented patient claims. Among these therapy options, the most frequently utilized medication is Hydroxyurea, which accounts for 68 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other UT PrescribersVs. UT Avg |
|---|---|---|---|
| Hydroxyurea | 68 | $22.64▼ below UT avg | ▲ More than typical |
About Hydroxyurea: This medication is used by people with sickle cell anemia to reduce the number of painful crises caused by the disease and to reduce the need for blood transfusions. Show more ▾ Some brands are also used to treat certain types of cancer (such as chronic myelogenous leukemia, squamous cell carcinomas). An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. In 2024, this provider wrote 68 Medicare prescriptions for Hydroxyurea, about 1.9 times the volume of the typical Utah prescriber of this medication (36). Medicare paid an average of $22.64 per fill, versus $25.23 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average UT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the UT average for this medication. 74 30-Day Fills standardized to 30-day supplies 2,175 Days of Medication total across all patients in 2024 | |||
| Dexamethasone | 36 | $9.59▼ below UT avg | ≈ Typical |
About Dexamethasone: Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye problems, breathing problems, bowel disorders, cancer, and immune system disorders. Show more ▾ It is also used as a test for an adrenal gland disorder (Cushing's syndrome). Dexamethasone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. An anti-inflammatory 9-fluoro-glucocorticoid. In 2024, this provider wrote 36 Medicare prescriptions for Dexamethasone, about the same volume as the typical Utah prescriber of this medication (31.8). Medicare paid an average of $9.59 per fill, versus $12.55 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average UT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the UT average for this medication. 36.2 30-Day Fills standardized to 30-day supplies 429 Days of Medication total across all patients in 2024 | |||
| Anastrozole | 32 | $6.67▼ below UT avg | ▼ Less than typical |
About Anastrozole: Anastrozole is used to treat breast cancer in women after menopause. Show more ▾ Some breast cancers are made to grow faster by a natural hormone called estrogen. Anastrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A nitrile and triazole derivative that acts as a selective nonsteroidal aromatase inhibitor. It is used in the treatment of ESTROGEN NUCLEAR RECEPTOR-positive breast cancer in postmenopausal women. In 2024, this provider wrote 32 Medicare prescriptions for Anastrozole, about 62% of the volume of the typical Utah prescriber of this medication (51.5). Medicare paid an average of $6.67 per fill, versus $16.27 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average UT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the UT average for this medication. 44 30-Day Fills standardized to 30-day supplies 1,320 Days of Medication total across all patients in 2024 | |||
| Ondansetron OdtOndansetron | 27 | $36.98 | ≈ Typical |
About Ondansetron Odt: This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. Show more ▾ It is also used to prevent and treat nausea and vomiting after surgery. Ondansetron works by blocking one of the body's natural substances (serotonin) that causes vomiting. A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties. In 2024, this provider wrote 27 Medicare prescriptions for Ondansetron Odt, about the same volume as the typical Utah prescriber of this medication (24.8). Medicare paid an average of $36.98 per fill, versus $16.16 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average UT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 27 30-Day Fills standardized to 30-day supplies 722 Days of Medication total across all patients in 2024 | |||
| BrukinsaZanubrutinib | 24 | $14,841.45 | ≈ Typical |
About Brukinsa: This medication is used to treat certain cancers (mantle cell lymphoma, marginal zone lymphoma, Waldenstrom's macroglobulinemia, chronic lymphocytic leukemia, small lymphocytic lymphoma, follicular lymphoma). Show more ▾ Zanubrutinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. A Bruton tyrosine kinase (BTK) inhibitor for treatment of Waldenstrom macroglobulinemia. In 2024, this provider wrote 24 Medicare prescriptions for Brukinsa, about the same volume as the typical Utah prescriber of this medication (23.5). Medicare paid an average of $14,841.45 per fill, versus $13,836.44 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average UT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 24 30-Day Fills standardized to 30-day supplies 720 Days of Medication total across all patients in 2024 | |||
| Enoxaparin Sodium | 22 | $268.11 | ≈ Typical |
About Enoxaparin Sodium: Enoxaparin is used to prevent and treat harmful blood clots. Show more ▾ This helps to reduce the risk of a stroke or heart attack. This medication helps keep your blood flowing smoothly by lowering the activity of clotting proteins in the blood. Enoxaparin is an anticoagulant, also known as a "blood thinner." It is a type of heparin. Conditions which increase your risk of developing blood clots include certain types of surgeries (such as knee/hip replacement, abdominal), long periods of being immobile, certain types of heart attack, and a specific type of chest pain called unstable angina. For some medical conditions, enoxaparin may be used in combination with other "blood thinners." Low-molecular-weight fragment of heparin, having a 4-enopyranosuronate sodium structure at the non-reducing end of the chain. It is prepared by depolymerization of the benzylic ester of porcine mucosal heparin. Therapeutically, it is used as an antithrombotic agent. (From Merck Index, 11th ed) In 2024, this provider wrote 22 Medicare prescriptions for Enoxaparin Sodium, about the same volume as the typical Utah prescriber of this medication (24.3). Medicare paid an average of $268.11 per fill, versus $132.00 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average UT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 22 30-Day Fills standardized to 30-day supplies 485 Days of Medication total across all patients in 2024 | |||
| EliquisApixaban | 18 | $658.39▼ below UT avg | ▼ Less than typical |
About Eliquis: Apixaban is used to prevent serious blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip/knee replacement surgery. Show more ▾ With atrial fibrillation, part of the heart does not beat the way it should. This can lead to blood clots forming, which can travel to other parts of your body (such as the lungs or legs) or increase your risk for stroke. In the United States, apixaban is also approved to treat certain types of blood clots (deep vein thrombosis-DVT, pulmonary embolus-PE) and to prevent them from forming again. Apixaban is an anticoagulant that works by blocking certain clotting proteins in your blood. An antithrombotic agent. In 2024, this provider wrote 18 Medicare prescriptions for Eliquis, about a quarter of the volume of the typical Utah prescriber of this medication (71.9). Medicare paid an average of $658.39 per fill, versus $942.52 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average UT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the UT average for this medication. 22 30-Day Fills standardized to 30-day supplies 643 Days of Medication total across all patients in 2024 | |||
| Amlodipine Besylate | 12 | $2.01▼ below UT avg | ▼ Less than typical |
About Amlodipine Besylate: Amlodipine is used with or without other medications to treat high blood pressure. Show more ▾ Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Amlodipine belongs to a class of drugs known as calcium channel blockers. It works by relaxing blood vessels so blood can flow more easily. Amlodipine is also used to prevent certain types of chest pain (angina). It may help to increase your ability to exercise and decrease the frequency of angina attacks. It should not be used to treat attacks of chest pain when they occur. Use other medications (such as sublingual nitroglycerin) to relieve attacks of chest pain as directed by your doctor. A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION. In 2024, this provider wrote 12 Medicare prescriptions for Amlodipine Besylate, about 13% of the volume of the typical Utah prescriber of this medication (95.8). Medicare paid an average of $2.01 per fill, versus $7.89 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average UT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the UT average for this medication. 20 30-Day Fills standardized to 30-day supplies 600 Days of Medication total across all patients in 2024 | |||
| Hydrocortisone | 11 | $24.45 | ▼ Less than typical |
About Hydrocortisone: This medication is used to treat a variety of skin conditions (such as insect bites, poison oak/ivy, eczema, dermatitis, allergies, rash, itching of the outer female genitals, anal itching). Show more ▾ Hydrocortisone reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a mild corticosteroid. The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. In 2024, this provider wrote 11 Medicare prescriptions for Hydrocortisone, about a third of the volume of the typical Utah prescriber of this medication (27.6). Medicare paid an average of $24.45 per fill, versus $22.65 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average UT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 329 Days of Medication total across all patients in 2024 | |||
| Prednisone | 11 | $4.84 | ▼ Less than typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2024, this provider wrote 11 Medicare prescriptions for Prednisone, about a third of the volume of the typical Utah prescriber of this medication (35.9). Medicare paid an average of $4.84 per fill, versus $4.53 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average UT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13 30-Day Fills standardized to 30-day supplies 228 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for JOSHUA GORDON RAMSAY DO, MBA is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Hematology & Oncology prescribing approach at this Ogden, UT practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among UT prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
